product summary
Loading...
company name :
MyBioSource
product type :
antibody
product name :
Anti-Lipoteichoic Acid Monoclonal Antibody
catalog :
MBS190780
quantity :
0.5 mg
price :
385 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
application :
ELISA, enzyme immunoassay
more info or order :
product information
catalog number :
MBS190780
products type :
Antibody
products full name :
Anti-Lipoteichoic Acid Monoclonal Antibody
products short name :
[Lipoteichoic Acid]
products name syn :
[Anti-Lipoteichoic Acid]
products gene name :
[LTA]
clonality :
Monoclonal
isotype :
IgG1
host :
Mouse
specificity :
This antibody reacts with lipoteichoic acid of Staph epidermidis, Hay strain, as well as clinical strains of Staph. epidermidis (types I, II, and III), Staph. aureus strains 5 and 8, Strep. pyogenes, Strep. fecaelis, and Strep. mutans. It does not react with peptidoglycan of Staph. aureus or peptidoglycanrhamnose, nor does it react with pneumococcal polysaccharides. This antibody does not cross-react with E Coli or H. influenzae type B.
form :
Protein G-purified antibody in PBS, pH 7.4
concentration :
1.67mg/ml
storage stability :
This antibody is stable for at least one (1) year at -20 degree C. Avoid multiple freeze-thaw cycles.
tested application :
ELISA (EIA)
app notes :
ELISA: Use at 0.1-1.0 ug/ml (optimized for LTA on solid phase). Opsonization assay: Use at 80-160 ug/ml (optimized for Staph. epidermidis, Hay strain).
other info1 :
Antigen: Staphylococcus epidermidis, Hay strain (ATCC #55133). Stabilizers: None. Preservatives: None. Appearance: Clear Liquid
other info2 :
Dilution Instructions: Dilute in PBS or medium which is identical to that used in the assay system.
products categories :
Infectious Disease Antibodies
products description :
Lipoteichoic acid (LTA) is the major proinflammatory structure present within the cell wall layer of most gram-positive bacteria. It plays an important role in the initiation and progression of bacterial infection, inflammation, and septic shock. LTA induces several cytokines in vivo, and LTA and peptidoglycan (PepG) synergize to cause the induction of nitric oxide formation which can lead to multiple organ failure. Since LTA is also found in the cell walls of non-pathogenic gram-positive bacteria, it has been suggested that the structure of LTA, and its ability to synergize with PepG, determines the ability of a particular bacterium to cause septic shock.
size1 :
0.5 mg
price1 :
385 USD
more info or order :
company information
MyBioSource
P.O. Box 153308
San Diego, CA 92195-3308
sales@mybiosource.com
https://www.mybiosource.com
1-888-627-0165
headquarters: USA
MyBioSource, LLC was orginally founded in Vancouver by three enthusiastic scientists who are passionate about providing the world with the best reagents available. Together, they form a company with a big vision known as MyBioSource. MyBioSource is now located in San Diego, California, USA.

"MyBioSource's number 1 vision is to be the world's number 1 quality reagents provider."

Our goal is to provide researchers, scientists and customers alike with a one-stop-shop for all of their reagents needs, whether it is monoclonal antibody, polyclonal antibody, recombinant protein, peptide, etc...

"MyBioSource offers the best products at unbeatable prices."

Please spend a few minutes to browse our online catalogs and see the wide range of products available. We ship our products through our shipping/distribution facility in San Diego, California, USA.

Would you like to receive email and e-newsletter from MyBioSource about new products, special offers and events? Please click here to join our Mailing List!